No abstract available
MeSH terms
-
Antineoplastic Agents, Hormonal / therapeutic use*
-
Combined Modality Therapy
-
Humans
-
Male
-
Neoplasm Staging
-
Prognosis
-
Prostatic Neoplasms / drug therapy*
-
Prostatic Neoplasms / pathology
-
Prostatic Neoplasms / radiotherapy*
-
Randomized Controlled Trials as Topic
-
Risk Factors
Substances
-
Antineoplastic Agents, Hormonal